Tracking Neulasta Injections for Cancer Treatment

Neulasta, self-administered by injection, is used by people undergoing cancer treatment.

The main journal description. The description field reminds this user that he must wait at least 24 hours. There is one attribute for “Dose”:

The “Dose” attribute is described as an Amount, with a unit of “syringe (6 mg / 0.6 mg)” and default amount “1″:

The resulting Event Entry screen:

Share
Tagged on: